Anemia in Acute Coronary Syndrome patients increases mortality risks after PCI: JAHA Deepanjana Sarkar28 Aug 2019 8:20 PM ISTBaseline anemia in Acute Coronary Syndromes (ACS) patients increases mortality risks after undergoing a Percutaneous Coronary Intervention (PCI),...
Alirocumab has maximum benefit in high risk patients or after CABG: ODYSSEY outcomes Deepanjana Sarkar30 Aug 2019 8:28 PM ISTPCSK9 Inhibitor Alirocumab benefits high-risk patients of polyvascular disease and those after CABG most according to ODYSSEY outcomes.Alirocumab,...
Another study confirms no mortality benefit of liberal use of oxygen in ACS patients: ESC 2019 Update Dr. Kamal Kant Kohli Kohli4 Sept 2019 8:20 PM ISTA new study has again failed to demonstrate a reduction in the risk of death at 30 days by liberal oxygen use when compared with a standard protocol...
Ticagrelor or Prasugrel?? Which antiplatelet therapy is best to treat ACS Deepanjana Sarkar5 Sept 2019 7:28 PM ISTPrasugrel and ticagrelor, novel antiplatelet agents have emerged as advanced oral antiplatelet therapy for patients with Acute Coronary Syndromes...
Risk stratification thresholds for high-sensitivity troponin I may speedily rule out MI with accuracy Deepanjana Sarkar10 Sept 2019 8:28 PM ISTRisk stratification thresholds for high-sensitivity cardiac troponin I may identify patients with suspected Acute Coronary Syndrome (ACS) with...
ESC releases new Guidelines for Diagnosis and Management of Chronic Coronary Syndromes Deepanjana Sarkar13 Sept 2019 7:00 PM ISTThe European Society of Cardiology has recently released guidelines for diagnosis and management of chronic coronary syndromes (CCS). The guidelines...
Woman develops takotsubo cardiomyopathy after eating large quantity of Wasabi: BMJ Case Reports Deepanjana Sarkar26 Sept 2019 6:00 PM ISTIt is truly said that too much of anything is bad. Recently a case of a woman who developed takotsubo cardiomyopathy after attending a wedding...
Evolocumab significantly reduces LDL-C in ACS patients: JACC Medha Baranwal Baranwal26 Sept 2019 8:20 PM ISTSwitzerland: Evolocumab, potent low-density lipoprotein cholesterol-lowering drug, may cause early reduction of LDL-cholesterol levels in patients...
